SIU Academy is a digital learning resource for urologists
Enter the portal

SIU Academy Governance 

 

Stavros Gravas

Stavros Gravas

MD, PHD, FEBU - Greece

Dr. Stavros Gravas became a qualified urologist in 1999 and was also qualified as Fellow of the European Board of Urology (FEBU) in the same year. In 2002, he attended the 12-month fellowship on Endourology (by the Endourological Society) at Minimal Invasive Urology Centre and Laparoscopy of the University Hospital in Nijmegen. In 2005, he received his doctorate degree from the University of Athens, and in 2007 his Ph.D. thesis entitled “Transurethral Microwave Thermotherapy for BPH – From Evidence-based Guidelines to Clinical Practice” from the University of Amsterdam. 

Dr. Gravas is the chairman of the European Association of Urology (EAU) Guidelines Working Group on BPH/male LUTS/BOO. He was member of the Committee on New Minimally Invasive and Surgical Developments in the management of Benign Prostatic Obstruction of the International Consultation on Prostate Diseases. Other working group memberships include the Editorial Board at Large of European Urology and European Urology Supplements, the Editorial Board of Journal of Endourology (serving as Section Editor on New Technologies). 

Dr. Gravas is a member of the Council of the Clinical Research Office of the Endourological Society (CROES) representing Europe and he served as member of the Board of the Directors of the Endourological Society until 2012. He is a member of many national and international societies and reviewer in European Urology, Journal of Urology, Urology, British Journal of Urology International, Journal of Endourology, International Journal of Urology, Current Urology, Clinical Drug Investigation and Hellenic Urology. 

Dr. Gravas is Assistant Professor of Urology (University of Thessalia) and works at the Department of Urology of the University Hospital of Larissa. His main fields of interest include medical and minimally invasive therapies for BPH, endourology, and stone management.

Sean P. Elliot

Sean P. Elliot

MD, MS, FACS - United States

Dr. Elliott is a Professor, Vice Chair of Urology and Director of Reconstructive Urology at the University of Minnesota. He directs a fellowship in Genitourinary Trauma and Reconstruction and the Urology Clinic at Gillette Lifetime Specialty Healthcare. He received his M.D. at Baylor College of Medicine in Houston, Texas and completed a urology residency and fellowship in Genitourinary Trauma and Reconstruction at the University of California-San Francisco. He earned a Master’s of Science in Health Services Research at the University of Minnesota and completed the program in leadership Development for Physicians in Academic Health Centers at Harvard University’s School of Public Health.

Dr. Elliott’s clinical interests include urethral stricture disease, male urinary incontinence, urinary diversion, male genital reconstruction and neurogenic bladder including the long-term bladder management of people with spina bifida or spinal cord injury. He directs a clinical and research fellowship in Genitourinary Trauma and Reconstruction, with the goal of training future leaders in this field.

Dr. Elliott is board certified in urology and a member of the American Urologic Association. He is a fellow of the American College of Surgeons. He is a member of the Board of Directors and serves as Secretary-Treasurer of the Society of Genitourinary Reconstructive Surgeons, the leading academic and clinical forum for reconstructive urology. In this role, he directs the day-to-day activities of the society and guides the Society’s long-term vision.

Dr. Elliott is a founding member of the Trauma and Urinary Reconstructive Network of Surgeons (TURNS). The University of Minnesota is one of 10 centers that collaborate in the study of patients treated for a variety of conditions in trauma and reconstructive urology. This network is designed to collect centralized data and provide sophisticated analysis of both surgical and patient reported outcomes from urethral stricture surgery, male incontinence and a variety of other conditions. This type of collaborative research effort is essential to moving forward outcome research that is increasingly important in modern medicine.

Dr. Elliott directs a urologic surgery outcomes research group at the University of Minnesota. His research has been funded by the National Institutes of Health, the Gillette Children’s Foundation and the American Cancer Society. His group seeks to improve the delivery of urologic care, particularly in 4 areas: (1) benign prostatic hyperplasia, (2) urethral stricture disease, (3) neurogenic bladder secondary to spina bifida, cerebral palsy or spinal cord injury, and (4) reducing complications of radiation or surgery for the treatment for prostate and cervical cancer.

SIU Academy Governance Committee

Peter Black

Peter Black

MD, FACS, FRCSC - Canada

Dr. Peter Black is a Urologic Oncologist at Vancouver General Hospital, a Research Scientist at the Vancouver Prostate Centre, and an Associate Professor in the Department of Urologic Sciences at the University of British Columbia (UBC). He received his undergraduate degree from the UBC and his medical degree from Johannes Gutenberg University in Mainz, Germany. He completed his urologic training at the University of Washington in Seattle and fellowship in urologic oncology at M.D. Anderson Cancer Center in Houston, Texas.  He has a clinical subspecialty interest in bladder cancer and a translational research program in urothelial carcinoma. This research focuses on the integration of advanced biomarkers and novel targeted therapies to promote precision oncology and is supported by peer-reviewed grant funding. He is actively involved in the design and conduct of clinical trials in genitourinary cancers. Dr. Black has 130 publications in both clinical and translational research domains. He is on the editorial board of six journals and reviews regularly for 24 journals. He participated in the 2014-15 American Urological Association Leadership Program and sits on the Board of Directors of the Société Internationale d’Urologie.

Jean de la Rosette

Jean de la Rosette

MD - Turkey

Dr de la Rosette is Professor in Urology at Amsterdam UMC University Hospital in Amsterdam (the Netherlands) and Professor in Urology at Istanbul Medipol University, Istanbul (Turkey). He completed his medical degree and urology residency at St Radboud University Hospital in Nijmegen, the Netherlands. His main fields of interest are minimal invasive surgery and endourology with a special focus on ablative treatments and urological ultrasound. Dr de la Rosette is a member of the committee on Minimal Invasive Treatment of Benign Prostatic Hyperplasia (BPH) and the committee on Upper Urinary Tract Urothelial tumors of the ICUD. He is also co-chairman of the committee on Renal Stone Disease of the ICUD. He is past-chairman of the EAU Section of Uro-Technology (ESUT) and board member of the Society of Endourology. Dr. de la Rosette was a chairman of the European Association of Urology (EAU) working party on BPH guidelines. Dr de la Rosette is (co)author of over 700 peer-reviewed publications and has authored many book chapters. Dr de la Rosette is a member of various urological societies and board member of the Endourological Society and the Société International d’Urologie (SIU). Since 2016 he holds the position of General Secretary of the SIU.

Reynaldo G. Gomez

Reynaldo G. Gomez

MD, FACS - Chile

Dr Reynaldo Gómez obtained his MD degree from the Catholic University of Chile School of Medicine in 1978. He then completed a residency program in general surgery and urology, obtaining a Master of Surgery degree and a Specialist in Urology degree in 1984 from the same school. He completed his training with a postdoctoral fellowship at the University of California, San Francisco School of Medicine, and the San Francisco General Hospital in 1991.

Dr Gómez started the Urology Service at the Hospital del Trabajador in Santiago, Chile, in 1984, and has been its chief since then. He was appointed associate professor of urology at the Andrés Bello University School of Medicine in 2011.

Dr Gómez is a member of many scientific societies and was president of the Chilean Society of Urology in 2001–2002. He has served on the Board of the Confederacion Americana de Urologia and was president of the Genitourinary Reconstructive Surgeons Society (GURS) in 2010. Dr Gómez is a reviewer on the editorial boards of the Chilean Journal of Surgery, the Chilean Journal of Urology, Urology (the Gold Journal), and the International Urology and Nephrology Journal.

Dr Gómez has been involved with the SIU since 2000, serving as the Chilean delegate from 2001 to 2010. He served in the SIU BOC from 2004 to 2011, as chairman of the Publications Committee and then as chair of the Internet and Telecommunications Committee. 

Simon Tanguay

Simon Tanguay

MD, FRCSC - Canada

Dr Tanguay completed his residency training at McGill University in 1992 and his fellowship in urologic oncology at the University of Texas M. D. Anderson Cancer Center in 1995.  He is currently Professor and Chairman of the Division of Urology at McGill University and the M. Elhilali and D. Azrieli Chair in urologic sciences.

Dr Tanguay was actively involved in the Quebec Urological Association where he served as president of the Continuing Medical Education committee from 2001 to 2004 and served as treasurer of this association.  He was Co-Director of the clinical research unit within the Division of Urology at McGill University.

Dr Tanguay served as member of the executive committee of the Genito-Urinary group at the National Cancer Institute of Canada and as the Chair of the Canadian Kidney Cancer Information System from 2009 to 2016.  He was the General Secretary of the Société Internationale d’Urologie from 2011 to 2016 and now serves as President Elect.

Faysal Yafi

Faysal Yafi

MD, FRCSC - United States

Dr. Yafi earned his medical degree from the American University of Beirut, Lebanon in 2005 after completing his undergraduate degree in Biology at the same institution in 2001. He then served his internship in General Surgery in the Department of Surgery at the American University of Beirut in 2006 before transferring to the Mayo Clinic in Rochester, Minnesota where he completed a year of preliminary surgery in the Department of Surgery in 2007. He subsequently completed a two-year research fellowship in the Biology and Therapy of Bladder Cancer in the Division of Urology at McGill University in Montreal, Canada in 2009. He subsequently completed his residency in Urology at McGill University in 2014, receiving the Division of Urology Outstanding Resident/Fellow Teacher of the Year Award in 2014. He is currently in the second year of his fellowship in Andrology at Tulane University, where he also serves as Clinical Instructor of Urology.

Dr. Yafi is a Fellow of the Royal College of Surgeons of Canada (Urology). He has previously served as chairman of the Northeastern Section of the AUA Residents Committee and member of the AUA Residents Committee. He is currently a member of the Sexual Medicine Society of North America Young Clinicians Committee. He has received multiple awards and recognitions, including the first prize essay contest of the Canadian Urological Association. Dr. Yafi has an avid interest in both basic and clinical research, with over 40 peer-reviewed publications and book chapters. His areas of focus include Peyronie’s disease, erectile dysfunction, androgen replacement therapy, prosthetic surgery (inflatable penile prosthesis and artificial urinary sphincter), male infertility, and urethral reconstruction.

Jack Zuckerman

Jack Zuckerman

MD - United States

Dr. Zuckerman attended medical school at Wake Forest University School of Medicine.  He completed an internship in General Surgery at the Naval Medical Center in San Diego and then went on to complete Urology residency at Eastern Virginia Medical School in Norfolk, Virginia.  He finished his training at EVMS with a fellowship in genitourinary reconstructive surgery.  He recently returned to California and is faculty at the Naval Medical Center in San Diego.

Dr. Zuckerman’s research interests are primarily focused on male reconstruction, including ongoing prospective randomized controlled trials, basic science animal models and large clinical databases.  While his focus is on urologic reconstruction he has published on a variety of other urologic topics, including oncology and general urology.

SIU Academy Education Council

Guosheng Yang

Guosheng Yang

MD, PhD - China

Stavros N Charalampous

Stavros N Charalampous

Md, PhD, FEBU - Cyprus

Julian Struck

Julian Struck

MD - Germany

Petros Sountoulidis

Petros Sountoulidis

MD, PhD, FEBU - Greece

Peter Chiu

Peter Chiu

MBChB, FRCSEd, FHKAM - Hong Kong

Belinda F. Morrison

Belinda F. Morrison

MB BS, (Hons), DM (Urol) - Jamaica

Masatoshi Eto

Masatoshi Eto

MD - Japan

Rami Al-Azab

Rami Al-Azab

MD - Jordan

James Ikol

James Ikol

MD - Kenya

Jun Hyuk Hong

Jun Hyuk Hong

MD - Korea

Poongkodi Nagappan

Poongkodi Nagappan

MD, FRCS (Urol) - Malaysia

Joseph Kunju Mathew

Joseph Kunju Mathew

MD - Oman

Sultan Alkhateeb

Sultan Alkhateeb

MD - Saudi arabia

Boubacar Fall

Boubacar Fall

MD - Senegal

John Lazarus

John Lazarus

MD - South Africa

Shing-Hwa Lu

Shing-Hwa Lu

MD, PhD - Taiwan

Mehmet Giray Sönmez

Mehmet Giray Sönmez

MD - Turkey

Mohsen Elmekresh

Mohsen Elmekresh

MD - United Arab Emirates

Sub-committees

Bladder and Upper Urinary Tract TCC

François Audenet

François Audenet

MD - France

Dr Francois Audenet is assistant professor in the Department of Urology at Hôpital Européen Georges-Pompidou in Paris, France.

Dr Audenet received his medical degree in Paris from Sorbonne Université – Faculté de Médecine Pierre et Marie Curie and completed his education with residencies in General Surgery and Urology at Paris University Hospitals.

After obtaining a research master’s degree in Surgical Science (2011) and completing surgical training in 2012, he was granted  the Gold Medal in Surgery, awarded each year to the best resident enrolled in the surgical program of Paris University Hospitals. He then completed  fellowship training in minimally invasive surgery and Urologic Oncology at Institut Mutualiste Montsouris in Paris, followed by a Urologic Oncology Fellowship at the David Solit Lab, Memorial Sloan Kettering Cancer Center in New York, USA.

Dr Audenet is dedicated to urological oncology and minimally invasive surgical techniques, and is engaged in research and teaching duties at his institution. He has published more than 75 peer-reviewed research papers and he reviews paper submissions for several urological journals. His research is primarily focused on oncology, particularly oncogenetics in urothelial carcinoma.

Ashish Kamat

Ashish Kamat

MD - United States

Dr. Ashish M. Kamat is an Associate Professor and Attending Surgeon in the Department of Urology/Division of Surgery at the MD Anderson Cancer Center in Houston, Texas. He is also the Director of the Urologic Oncology Fellowship Program at the same institute. 

Dr. Kamat is an internationally recognized expert in urologic oncology. He has a special interest in cancers of the bladder and prostate, with an emphasis on organ-sparing therapies, minimally invasive techniques (e.g., robotic surgery), and orthotopic bladder substitution (neobladder). While he is a busy, clinically active surgeon, he maintains an active research portfolio in order to improve the care for patients. In the clinical arena, in concert with efforts to develop novel therapies, Dr. Kamat’s efforts are directed toward identifying predictors of response to therapy, as a first step toward personalized cancer therapeutics. A major focus of his laboratory research is to develop novel therapies for bladder cancer using an approach which encompasses novel use of existing agents, the identification of novel targets and therapies, or a combination of these strategies.

Dr. Kamat has authored numerous editorials and more than 150 publications in prestigious peer-reviewed journals, and serves on the editorial board of Expert Reviews in Anticancer and F1000 Reviews. His basic, translational, and clinical research is funded by peer-reviewed awards including ones from the National Cancer Institute (NCI). He serves as project principal investigator (PI) on the MD Anderson Cancer Center GU (Bladder) SPORE (which stands for Specialized Programs of Research Excellence), which is the only one of its kind in the country. He has served as a member on the NCI Bladder Cancer task force and Grant Review Committees (such as NIH-RO1 study sections), and for various international societies (such as the Dutch Cancer Society and NIH—Singapore). 

Dr. Kamat is listed in ‘Who’s Who in Medicine’ and ‘Best Doctors in America,’ and has received the ‘Compassionate Doctor Award.’ He is active in many cancer support groups, such as the MD Anderson Bladder Support Group (for which he serves as Medical Director), as well as the Bladder WebCafe and Bladder Cancer Advocacy Network (BCAN). 

Dr. Kamat is an active member of the urologic community, and a graduate of the American Urological Association (AUA) Leadership Program. He serves on the Board of Directors for the South Central Section (SCS) of the AUA and is The State Representative (Texas) for Urology.

Manish Patel

Manish Patel

MD, PhD - Australia

Prof. Dr.  Manish Patel is a urological oncologist working at Westmead Hospital, the University of Sydney, and Macquarie University, in Sydney, Australia.

After medical school Prof. Patel completed his master’s degree in Cell Biology followed by a fellowship in Urology from the Royal Australasian College of Surgeons. He completed a Uro-oncology fellowship at Memorial Sloan Kettering Cancer Center, New York, and a doctoral degree in novel therapies for prostate cancer.

Currently Prof. Patel has a special clinical and research interest in bladder and prostate cancer. His research program focuses on quality of life evaluations, oncological outcomes and clinical trials. The research program has received over $5 million in grant income, and generated over 100 peer-reviewed publications, five books and seven book chapters. His research papers have been published extensively in many peer-reviewed journals and he is a regularly invited speaker to international urology meetings.

Prof. Patel is a member of several professional organizations including the Urological Society of Australia and New Zealand, the Royal Australasian College of Surgeons American Urological Association (committee member), the European Association of Urology (EAU), Society International d’Urologie (SIU) and Society of Urologic Oncology (SUO).

Rafael Sanchez-Salas

Rafael Sanchez-Salas

MD - France

Dr. Rafael Sanchez-Salas is a urological surgeon at the Institut Mutualiste Montsouris in Paris, France.  He received his medical degree from the Universidad de los Andes (ULA) in Mérida, Venezuela, followed by general surgery and urological training at the Hospital Universitario de Caracas, also in Venezuela.

After basic training, Dr. Sanchez-Salas undertook research and clinical fellowship training in urological oncology and minimally invasive urological surgery at Memorial Sloan-Kettering Cancer Center in the United States, Clínica Santa María in Chile, and the Institut Mutualiste Montsouris in France, where he eventually earned his spot as staff surgeon.

In addition to surgical work, Dr. Sanchez-Salas is an active academic urologist with international publications and ongoing collaborations in the field of urological oncology and minimally invasive surgery. He runs the Medical Education Office for the Confederación Americana de Urología (CAU), and he has recently been inducted to the Board of the European Robotic Urological Society (ERUS).

 

Infection and Inflammation

Tommaso Cai

Tommaso Cai

MD - Italy

Curtis Nickel

Curtis Nickel

MD, FRCSC - Canada

 

Lower Urinary Tract Dysfunction

Márcio Augusto Averbeck

Márcio Augusto Averbeck

MD - Brazil

Joyce Baard

Joyce Baard

MD - The Netherlands

Ijeoma N. C. Chibuzo

Ijeoma N. C. Chibuzo

MD - Nigeria

Dean Elterman

Dean Elterman

MD - Canada

Mauro Gacci

Mauro Gacci

MD - Italy

Mauricio Plata

Mauricio Plata

MD - Columbia

Satoru Takahashi

Satoru Takahashi

MD - Japan

 

Pediatrics and Transitional Urology

Erin McNamara

Erin McNamara

MD, MPH - United States

Dr. Erin R. McNamara is a pediatric urologist at Boston Children’s Hospital. She assists in the spina bifida center, performing complex reconstructive cases and helping with transitioning care of adolescent/young adult patients with complex urologic conditions. 

Dr. McNamara completed a six-year Urology residency at Duke University followed by a one-year fellowship in Cancer Survivorship and Reconstructive Urology at the same institution. She then completed a three-year Pediatric Urology fellowship at Boston Children’s Hospital. During that time she obtained her master’s degree in Public Health and completed a Health Services Research fellowship at Harvard. 

While both her clinical and research interests are primarily focused on the spina bifida population, she is also interested in other urologic conditions such as exstrophy, posterior urethral valves, disorders of sex development and complex hypospadias that need to be followed into adulthood. She first became interested in transitional urology during residency and spent her research time in fellowship developing projects to better understand the healthcare needs and utilization in this young adult population.  She has carried out both qualitative and quantitative research studying healthcare transition and has looked at outcomes in surgery using both local and national databases.

Dr. McNamara is passionate about establishing a transition program at her home institution. With her unique training in both adult reconstructive urology and pediatric urology, she is building fruitful collaborations with adult reconstructive providers to ensure her patients receive the care they need to lead productive and healthy lives.  

Madina Ndoye

Madina Ndoye

MD - Senegal

Dr Medina Ndoye is a consultant urologist at Grand Yoff General Hospital, in Senegal. In addition to general urology, her main clinical activities are oriented toward reconstructive urology for children and adults. Previously, she was the chief of the urology department at Ziguinchor Regional Hospital.

Dr Ndoye completed her medical studies at Cheikh Anta Diop de Dakar University in Senegal in 2006. She ranked first in the residency admission exam and trained for five years in urology surgery. She completed fellowships in Endourology and Incontinence Surgery (France) Cancer Epidemiology and Prevention (Maryland, USA), and Pediatric Reconstructive Urology Surgery (Pittsburgh, USA). Dr Ndoye also has a degree in environmental and global health.

As a consultant for UNFPA, WAHA and AMREF, she has participated in many national and international workshops on VVF surgery and training, in addition to participating in international conferences on the topic of urology. She is a member of many scientific societies including the American Urological Association (AUA),  AORTIC and Société Internationale D'Urologie (SIU).

Dr Ndoye has authored several publications. She is a member of several associations including the Association of Female Doctors of Senegal (AFEMS), the Senegalese Association for Family Welfare (ASBEF), and International Planned Parenthood Federation Planning ( IPPF). She is an active advocate of women’s health and empowerment. She is also an member (honor) of the LISCA Senegalese League against Cancer.

Barbara Rampersad

Barbara Rampersad

MBBS, FRCS, FRCS (Paed Surg) - Trinidad and Tobago

Dr. Barbara Rampersad is a paediatric surgeon/urologist practicing in Trinidad and Tobago. She completed her postgraduate training in the United Kingdom in 2004 at Alder Hey and Manchester Children's Hospital and completed fellowships at Westmead Children's Hospital in Sydney and Helsinki Children's hospital in Finland.

Dr. Rampersad is the sole paediatric urologist for the island of 1.4 million people, therefore she sees a variety of conditions. She is also a lecturer at the University of the West Indies; her goal is to train upcoming surgeons in paediatric urology.

Dan Wood

Dan Wood

PhD, FRCS(UROL) - United Kingdom

Mr Dan Wood is a Consultant in Adolescent and Reconstructive Urology at University College London Hospitals. He earned his PhD from St Bartholomew’s Hospital Medical School in 1994.

Dan’s principle surgical interest is in major lower urinary tract function and reconstruction in adolescence, particularly with congenital anomalies. He performs major surgical reconstruction for patients with conditions such as bladder exstrophy, disorders of sex development, and spina bifida. He has expertise in augmentation and substitution cystoplasty, ileal conduit, mitrofanoff channels and genitoplasty, including vaginal reconstruction.

Dan did his research and gained his PhD in 2003 with Professor Chris Fry at UCL, looking at cultured bladder cells and their physiology. He continues to maintain a research interest in cell culture and its application, as well as long- term outcomes in adolescent urology.

He is the clinical lead for paediatric surgery and the acute surgical unit, Editor of the Journal of Paediatric Urology, Chairman of the newly formed Congenital Lifelong Urology Working Group in Europe, Patron of the Mitrofanoff Support Charity and a Trustee of the St Peter’s Trust. He is an alumnus of the NHS Staff College Leadership training programme.

Hadley Wood

Hadley Wood

MD - United States

Dr. Hadley Wood is staff urologist at the Cleveland Clinic  and Assistant Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. She has developed a multidisciplinary clinic for adults with spina bifida and serves as an adult specialty advisor to the Transition Services Group of the Cleveland Clinic’s Children’s Hospital.

Dr. Wood received her undergraduate degree from Duke University and medical degree from Johns Hopkins University School of Medicine. After training at the Cleveland Clinic Glickman Urological and Kidney Institute, she joined the faculty and is currently a member of the Center for Genitourinary Reconstruction.  She has carried out basic science research at the Institute for Molecular Medicine in Oxford, England and the Lerner Research Institute at Cleveland Clinic. 

Her area of subspecialty is genitourinary reconstruction with a focus on adolescents and adults with urological congenital defects. These include older patients with exstrophy spectrum, cloacal anomalies, hypospadias, and myelomeningocele. She also cares for adolescents and adults with congenital neurological disorders that have resulted in urological problems, such as muscular dystrophy and cerebral palsy.

In addition to full time clinical responsibilities and resident teaching, Dr. Wood is continuously involved in clinical research and her work has been published in a number of peer-reviewed journals. She serves as section editor for Urology (Congenitalism) and as a peer reviewer for many other journals. She has written nine book chapters related to her specialty areas and has co-edited a textbook on urological congenitalism.

She has been an active member of several societies, including the AUA, Society of Genitourinary Reconstructive Surgeons, Society of Urodynamics and Female Urology, American College of Surgeons, Society of Women in Urology, Cleveland Clinic Women’s Professional Staff Association, Ohio Urological Association and Alpha Omega Alpha. 

Dr. Wood is involved in mentoring and developing resources for women urologists and surgeons within her institution and nationally, and serves as founding Co-chair of the Northeast Ohio Women in Surgery Group and as president as the Women’s Professional Staff Association at the Cleveland Clinic.

 

Reproductive and Sexual Health

Jim Hotaling

Jim Hotaling

MD, MS, FECSM - United States

Dr. Hotaling has significant training in both the clinical aspects of male fertility and genetic epidemiology and he is currently the only fellowship trained male infertility/andrology expert in Utah. He completed a 6-year residency in urology at the University of Washington, elected to pursue a year of sub-specialty training in male infertility with Craig Niederberger at the University of Illinois Chicago. He has a long-term research goal of developing novel genetic markers for male infertility that can be used clinically to diagnose and treat this devastating condition.

He has seen and performed surgery on hundreds of men with male infertility and is an associate editor of Fertility and Sterility, a premier journal in the field that has had significant extramural research funding and has over 25 publications. He obtained an MS in clinical epidemiology in 2010 with a focus on statistical genetics and conducted the first genetic study on erectile dysfunction at the University of Washington.

His prior work on building the male fertility cryopreservation databank at the University of Washington resulted in the creation of the largest US database of men cryopreserving sperm for cancer. While at the University of Illinois Chicago, he initiated studies on the genetics of male infertility. As part of this collaboration, he established a protocol for the collection and banking of DNA and serum and linkage to a de-identified database, gMR, an infertility specific electronic medical record. gMR allows uniform phenotyping and is going to be used by several members of a CDC working group for research collaboration.

Konstantinos Rokkas

Konstantinos Rokkas

MD - Greece

Dr. Rokkas graduated the Medical School of the University of Athens in 1994 and served his military service in the Navy as an Officer from 1994 to 1996. He then worked in the dialysis unit of the County Hospital of Chalkida in rural service. He specialized in Urology at the Ippokrateio Hospital in Athens from 1998 to 2002. During 2002-2003 he had his post practice in andrology at the University Hospital San Raffaele in Milan, as a fellow of Professor Francesco Montorsi. From June 2003 to March 2014, he was the Director of the Organic Section at the Institute of Sexual Health in Athens, Greece. From April 2010 to April 2014 he was directing the Medical Center of Sexual Health in Nicosia, Cyprus. From January 2014 he is the director of the Athens Andrology and Urology Center. In November 2010 he started practicing shock wave treatments using the ED1000 device in erectile dysfunction patients. Until now he has treated about 1400 patients using the ED1000 device.

Dr. Rokkas is a PhD candidate at the University of Athens, research associate of the Cardiology University Clinic, former Treasurer of the Hellenic Urological Association and a member of various scientific societies. He has attended more than 200 Greek and international conferences and has participated in over 180 international and Greek scientific publications and announcements.

In 2005, he received the award for Best Publication in EUROPEAN UROLOGY and in 2008 the prize of best clinical presentation to the Congress of the European society of sexual medicine (ESSM) in Brussels.

Sarah C. Vij

Sarah C. Vij

MD - United States

Sarah C.Vij, MD is an Associate Staff in the Department of Urology at the Cleveland Clinic Foundation. She obtained a Bachelor of Arts from Amherst College and her medical degree from Feinberg School of Medicine at Northwestern University. She then completed her residency training in urology at the Cleveland Clinic Foundation. After completing residency, she did a fellowship in male infertility and andrology at the Cleveland Clinic Foundation. Dr. Vij is on faculty in the Glickman Urologic and Kidney Institute and serves as fellowship director for the male infertility fellowship at Cleveland Clinic.

Faysal Yafi

Faysal Yafi

MD, FRCSC - United States

Dr. Yafi earned his medical degree from the American University of Beirut, Lebanon in 2005 after completing his undergraduate degree in Biology at the same institution in 2001. He then served his internship in General Surgery in the Department of Surgery at the American University of Beirut in 2006 before transferring to the Mayo Clinic in Rochester, Minnesota where he completed a year of preliminary surgery in the Department of Surgery in 2007. He subsequently completed a two-year research fellowship in the Biology and Therapy of Bladder Cancer in the Division of Urology at McGill University in Montreal, Canada in 2009. He subsequently completed his residency in Urology at McGill University in 2014, receiving the Division of Urology Outstanding Resident/Fellow Teacher of the Year Award in 2014. He is currently in the second year of his fellowship in Andrology at Tulane University, where he also serves as Clinical Instructor of Urology.

Dr. Yafi is a Fellow of the Royal College of Surgeons of Canada (Urology). He has previously served as chairman of the Northeastern Section of the AUA Residents Committee and member of the AUA Residents Committee. He is currently a member of the Sexual Medicine Society of North America Young Clinicians Committee. He has received multiple awards and recognitions, including the first prize essay contest of the Canadian Urological Association. Dr. Yafi has an avid interest in both basic and clinical research, with over 40 peer-reviewed publications and book chapters. His areas of focus include Peyronie’s disease, erectile dysfunction, androgen replacement therapy, prosthetic surgery (inflatable penile prosthesis and artificial urinary sphincter), male infertility, and urethral reconstruction.

 

Stone Disease and Endourology

Sero Andonian

Sero Andonian

MSC, MDCM, FRCS(C) - Canada

After obtaining his Bachelor of Science degree (First Class Honours, Dean’s Honour List) in Anatomy and Cell Biology at McGill University, Dr. Andonian pursued a Master of Science degree at the same university with his thesis entitled “Structure and function of the rat vas deferens”. Dr. Andonian obtained his MDCM degree from McGill University in 2002 and completed Urology residency training at McGill University Health Centre in 2007. In order to further develop his minimally invasive techniques, Dr. Andonian completed a two year Endourology fellowship at the prestigious North Shore-Long Island Jewish Health System, under the supervision of Dr. Louis Kavoussi and Dr. Arthur Smith.

 In July 2009, he was appointed Assistant Professor of Surgery (Urology) at McGill University and has been an Attending Urologist at the McGill University Health Centre. To further develop his pedagogical skills, Dr. Andonian completed Teaching Scholars Program for Educators in Health Sciences in 2011.

 Since his faculty appointment, Dr. Andonian has been active in clinical research, including: teaching minimally invasive procedures for treatment of kidney stones, assessing determinants of fluoroscopy usage during endourologic procedures, and determining whether training on simulators improves endourologic surgical outcomes. In addition to minimally invasive procedures and radiation safety, Dr. Andonian is involved in active clinical research regarding medical management of kidney stones. He has received research grants from the Quebec Urological Association, the Canadian Urological Association Scholarship Fund, the Northeastern AUA Young Investigator Award, and most recently he has been awarded the prestigious Chercheur Boursier Clinicien from Fonds de Recherche Santé Québec for the 2013-2017 period.

 He has published over 70 peer-reviewed manuscripts. In addition, he has authored nine book chapters including two chapters in the Smith’s Textbook of Endourology and the chapter on “Surgical, Radiological, and Endoscopic Anatomy of the Kidney and Ureter” in the 11th edition of Campbell-Walsh Urology. Furthermore, he has produced 11 educational videos in the field of endourology. Dr. Andonian has given plenary lectures and courses at several national and international meetings including the Canadian Urological Association (CUA), American Urological Association (AUA), and Société Internationale d’Urologie (SIU) Annual Meetings. He has won several prizes, including the Everett Reid Teaching Excellence Award in 2011 and the Best Laparoscopic Paper at the World Congress of Endourology in 2008. Recently, he has participated in both CUA’s guidelines on ureteral stones and the SIU’s International Consultation on Stone Disease. Currently, Dr. Andonian is on the CUA Executive Committee and editorial boards of Canadian Urological Association Journal and Videourology: Journal of Endourology.

Vitor Cavadas

Vitor Cavadas

MD - Portugal

Dr. Vitor Cavadas is a consultant in the Department of Urology at Santo António General Hospital, Porto, Portugal, and is Head of the Stone Unit within this department. He is also involved in the pre-graduate teaching of Urology at Abel Salazar Biomedical Sciences Institute in Portugal.

Dr. Cavadas graduated from medical school at the Faculty of Medicine of Porto in Portugal (2002). He completed his general internship at St. John’s Hospital in Porto (2003–2004) followed by his residency in Urology at the Santo António General Hospital, in Porto (2005–2010).

Dr. Cavadas is a member of the Portuguese Association of Urology, the Portuguese Society of Andrology and the European Association of Urology. He has participated in several clinical trials and authored many scientific articles in peer-reviewed journals. He was awarded a research grant by the Portuguese Association of Urology.

 

Ranan Dasgupta

Ranan Dasgupta

MBBChir, MA, MD, MRCS, FRCS(Urol) - United Kingdom

Dr. Ranan DasGupta followed graduation from Cambridge University medical school, with a higher degree in Neuro-urology at Queen Square (UCL, London) and pioneering studies of sacral neuromodulation, medical cannabinoids, intravesical botulinum toxin and use of PDE5 inhibitors in neuropathic sexual dysfunction.

He also sub-specialised in Endourology, for which he is the clinical lead at Imperial College Healthcare (London). Based at the leading tertiary centre in west London, the department offers comprehensive stone management, both surgical and medical, with over two decades of experience in  all treatment options. As the main cancer centre, his interest in upper tract urothelial cancer has been maintained, with studies of upper tract photodynamic therapy presented internationally.

Having published numerous peer-reviewed papers, and contributed to several book chapters (and co-editing a textbook on Urinary Tract Infection), he has also been local Principal Investigator for several national research studies (TISU, PURE, UK ROPE), maintaining his interest in clinical and basic research; he is a reviewer for 5 journals. Selected as an examiner for both undergraduate (MBBS) and postgraduate (FRCS(Urol)) levels, he remains committed to maintenance of educational standards.

Selcuk Guven

Selcuk Guven

MD - Turkey

Selcuk Guven received his medical degree from Erciyes University Medical Faculty in 1998. He was awarded specialist certification in Urology from Selcuk University Meram Medical School (Director Prof. Kilinc) in 2005, where he served as a clinical instructor and subsequently Assistant Professor. As a visiting scholar, he gained experience in andrology with Prof. Kadioglu. From 2007-2008, he worked on laparoscopy training and joined the Turkish Urological Laparoscopy Group (Turkurolap). In 2008-2009, he completed a 4-month fellowship training program in laparoscopy at Klinikum Heilbronn Teaching Hospital under the surveillance of Prof. Rassweiler. He was involved with the CROES Project in 2010 and consulted with Prof. de la Rosette and Prof. Laguna in the Academic Medical Centre as a clinical fellow in laparoscopy and endourology. He became Associate Professor in 2012. He served as an organizing committee member and trainer in national and international urology courses and symposia. Dr. Guven participated as a live surgeon in the symposia and one-to-one training meeting organized by Turkurolap and the Turkish Endourology Society. He has published more than 50 peer-reviewed manuscripts and numerous book articles, abstracts and conference presentations. He has served as an Editorial Board Member of European Medical Journal Urology since 2014 and was appointed Associate Editor of The New Journal of Urology in 2016 and Endourology Bulletin of Turkish Endourological Society in 2017. He is a member of the Turkish Endourological Society Board of Directors, Turkish Proficiency Board of Urology and the General Secretary of the Joint Turkish Board of Urology. Dr Guven's primary interest is in minimally invasive management of urinary tract stone disease and endourology and he is currently working in the Urology Department of Istanbul Medipol University.

Amit Kalpee

Amit Kalpee

MD - South Africa

Dr. Kalpee completed his undergraduate degree at the University of KwaZulu-Natal, Nelson R Mandela school of medicine. He subsequently completed post graduate qualifications in Pretoria Academic Hospital, University of Pretoria and completed his fellowship with the College of Surgery (Urology) in Durban, South Africa at Inkosi Albert Luthuli Central Hospital.

He has always had a keen interest in Endourology and was instrumental in opening the first stone clinic in the country at Inkosi Albert Luthui Central Hospital. He also was responsible as a registrar, of creating and running the first dedicated Stone Unit in the province with a dedicated stone theatre offering ESWL, Ureteroscopy and PCNL.

His post graduate training involved a research fellowship with Professor Olivier Traxer and Professor Andries Hosnek in Paris covering flexible ureteroscopy and supine PCNL. He has completed a Holmium laser enucleation masterclass with Professor Scoffone in Turin, Italy. He was the only South African awarded the International Endourology fellowship in 2012 with Professor Monga at the Cleveland Clinic.

Dr Kalpee is currently a practicing Endourologist in Durban with interest in stone disease and holmium laser enucleation of the prostate. He is proficient in performing ureteroscopy and laser lithotripsy having performed more than five hundred procedures. He is currently also the only surgeon in the country performing supine percutaneous nephrolithotomy, having performed more than one hundred punctures. Dr Kalpee was also the first Urologist in the country to perform Holmium Laser Enucleation of the prostate and is the founding member of the South African Holmium User Group (SAHUG).

Dr Kalpee has presented at several endourology meetings both nationally and internationally, including the Expert in Stone Disease Meetings and the World Congress of Endourology. He is also a keynote speaker for Boston Scientific, Bayer medical and Karl Storz. He is a member of the International Endourology society and the Southern African Endourology Society. His publications include Supine PCNL and demographics of renal calculi patients in Kwazulu-Natal. 

Athanasios Papatsoris

Athanasios Papatsoris

MD, MSc., PhD, FEBU - Greece

Prof. Athanasios Papatsoris is Assistant Professor of Urology at the 2nd Department of Urology, School of Medicine, Sismanoglio General Hospital in Athens Greece.

Prof. Papatsoris graduated from the University of Patras School of Medicine with an honorary scholarship, and from the same university, earned a master of science degree in Pathobiochemistry with his thesis on benign prostatic hyperplasia (BPH). His doctoral thesis on bladder cancer was completed at the 2nd Department of Urology of Athens University.

He received his urology training in London and Athens, where he was certified as a Urological Surgeon. In London he completed a two-year Endourology fellowship, and in France, a clinical fellowship in Laparoscopy. He served as an honorary consultant in Urology at Royal London Hospital, Barts Health NHS Trust for one year. He obtained his Fellow of the European Board of Urology (FEBU) degree in Athens and has since been an FEBU examiner.

Prof. Papatsoris is an Associate Board member of the EAU Section of Urolithiasis (EULIS) and Secretary of the Hellenic (Greek) Urological Association (HUA). He is a Board member of the EAU Young Academic Urologists (Endourology Group), the European Board of Urology (EBU) National Delegate, the Societé Internationale d'Urologie (SIU) National Delegate, the HUA Section of Endourology – Laparoscopic Surgery and Urotechnology, the Institute of Molecular Medicine and Biomedical Research (IMIBE), and the Hellenic Genito-Urinary Cancer Group (HGUCG).

Prof. Papatsoris has more than 140 publications in PubMed indexed journals and is on the editorial board of 14 urology journals. He has participated as faculty in several international congresses, workshops and intensive courses across Europe, America, Middle East, Asia and Australia.

Daniel Perez-Fentes

Daniel Perez-Fentes

MD, PhD - Spain

Prof Dr. Pérez-Fentes heads the Endourology Unit in the University Hospital Complex of Santiago de Compostela in Santiago de Compostela, Spain. As part of his responsibilities, he organizes several national and international endourology training workshops and courses each year. He also holds the positon of Associate Professor in the School of Medicine at the University of Santiago de Compostela.

Dr. Daniel Pérez-Fentes received his medical degree from the University of Santiago de Compostela in Spain (2002) and continued his education, specializing in urology (2008). He completed his training at the Galdakao-Usansolo Hospital in Vizcaya, Spain, the Azienda Ospedaliera San Luigi di Orbassano in Turin, Italy and the Memorial Sloan-Kettering Cancer Center in New York, USA. He is a Fellow of the European Board of Urology (FEBU) as of 2011. His doctoral thesis was on the functional, systemic and quality of life effects of percutaneous nephrolithotomy (2013).

Dr. Pérez-Fentes lectures on endourology in international and national conferences, as well as performing live surgeries in numerous courses or congresses. He is editor of the book titled “Practical handbook on supine percutaneous nephrolithotomy” and he has authored 30 chapters in urological books and 49 scientific papers. Currently he is directing two doctoral theses on urinary stone management.

Dr. Pérez-Fentes is a member of the European Association of Urology (EAU), the Société Internationale d’Urologie (SIU) and the Spanish National Association of Urology (AEU). He is a member of the Galician Royal Academy of Medicine and Surgery as of 2016.

Satyendra Persaud

Satyendra Persaud

MD - Trinidad

Dr. Persaud completed his medical training at the University of Guyana in 2005. He did his internship and general surgery training at the Queen Elizabeth Hospital in Barbados. He completed his residency in Urology at the San Fernando General Hospital, which is a University of the West Indies teaching hospital. It is also a member of the SIU Academy sub-committee on Stone Disease and Endourology. He also has served as Organizing Secretary of the Caribbean Urological Association for the past 3 years. He has an interest in uro-oncology, urolithiasis and reconstruction. He also enjoys cricket and fishing.

Mohammad Radfar

Mohammad Radfar

MD - Iran

M Hadi Radfar, MD, is Assistant Professor of urology and co-director of fellowship program at National Center of Excellence in Iran, Shahid Labbafinejad Medical Center. He completed his urology residency in 2010 and achieved the first rank in National Board Exam. He then completed a two-year fellowship in advanced Endourology and Urolaparoscopy. He is a member of Innovation and Technology Committee of Société Internationale d’Urologie (SIU). He is also a member of Executive Committee and Board of Directors of Iranian Endourology and Urolaparoscopy Society. In Iranian Urological Association (IUA), he holds the position of deputy chairman of young urologists committee.

Dr. Radfar’s primary surgical, clinical, and research interests include minimally invasive management of stones, laparoscopy of kidney and ureter, and management of bladder cancer. He has published over 40 manuscripts in peer-reviewed literature.

Sabnis Ravindra

Sabnis Ravindra

M.S., M.Ch. (Urology) - India

Dr. Ravindra Sabnis is Chairman of the Department of Urology and consultant urologist at the Muljibhai Patel Urological Hospital (MPUH) in Nadiad, India. In the past, he held the positions of council member, secretary, and president of the Urological Society of India West Zone. He was also Chairman of the Board of Education and a past governing council member of the Urological Society of India. Dr. Sabnis is a recognized teacher and examiner for the National Board of Examinations in New Delhi, India for more than 20 years.

 

He is an active member of several urological societies including the Société Internationale d’Urologie, the World Endourological Society, the American Urological Association, the Urological Association of Asia, the Urological Society of India, and the Nepal Urological Association.

 

Dr. Sabnis has presented over 150 papers in national and international conferences and has received numerous awards for best paper, poster, and video categories. He has also been invited as guest lecturer nationally and in many international conferences. He has participated in more than 50 live surgery workshops in India and abroad.

 

Dr. Sabnis has published over 100 papers in peer-reviewed journals and was co-author of eight book chapters and author of one book. He serves as a reviewer for several journals including the World Journal of Urology, Urology, the British Journal of Urology, the Journal of Endourology, the Indian Journal of Urology, as well as the Journal of Urology.

 

SIU-ERAS Programme Committee

Justin Collins

Justin Collins

MD - United Kingdom

Hooman Djaladat

Hooman Djaladat

MD, MS - United States

James Douglas

James Douglas

MD - United Kingdom

Lucy Fairchild

Lucy Fairchild

RN - United Kingdom

Ashish Kamat

Ashish Kamat

MD - United States

Kelly Mayson

Kelly Mayson

MD - Canada

Julian Smith

Julian Smith

MD - United Kingdom

Stephen B. Williams

Stephen B. Williams

MD - United States

Trauma and Reconstruction

Benjamin Breyer

Benjamin Breyer

MD - United States

Dr. Breyer graduated from the University of Chicago Pritzker School of Medicine. He attended residency at the University of California San Francisco.  Breyer completed a fellowship in complex male genitourinary reconstruction and trauma surgery under the direction, of Jack W. McAninch, MD.  Breyer was invited to join the faculty in 2011. In 2014, he was named Chief of Urology, San Francisco General Hospital.

Breyer’s clinical interests include complex urethral and penile reconstruction, male incontinence, male fistula, surgical treatment for erectile dysfunction, and transgender surgery. He is expert in both minimally invasive and complex open reconstructive surgery.

Breyer’s primary research interests involve studying the epidemiology of sexual dysfunction, lower urinary tract symptoms, and trauma and reconstruction.   He is NIH supported and has authored or coauthored over 150 articles and book chapters. Breyer is a member of the Trauma and Urinary Reconstructive Network of Surgeons (TURNS - http://turnsresearch.org).

Jessica DeLong

Jessica DeLong

MD - United States

Dr. Jessica DeLong is a urologist in Virginia Beach, Virginia and is affiliated with Chesapeake Regional Healthcare.

Dr. DeLong completed her undergraduate degree in biology and Spanish at the University of Virginia in 2003. She earned her medical degree from Eastern Virginia Medical School in Norfolk, Virginia in 2007 and was appointed to the Alpha Omega Alpha honors society. Both her surgery internship and Urology residency were completed at the Lahey Clinic in Burlington, Massachusetts. She went on to complete a fellowship in Adult and Pediatric Reconstructive Urology at Eastern Virginia Medical School in 2014.

Dr. DeLong specializes in pelvic floor and genitourinary reconstruction, including male urethral stricture, Peyronie’s disease, erectile dysfunction, male and female incontinence, female prolapse and complicated urinary disorders. She is a member of the American Urological Association (AUA), Genitourinary Reconstructive Surgeons (GURS), Société Internationale d’ Urologie (SIU) and Society of Women in Urology (SWIU).

Dr. DeLong has published in several journals and text books. She has presented her research widely, both at national and international levels. She is committed to working in resource-poor settings and has traveled with IVUmed while in training and as a visiting professor. She has worked extensively as an international medical educator (IME) with Physicians for Peace.

Stella Ivaz

Stella Ivaz

MD - United Kingdom

Stella Ivaz qualified from St George's – University of London and has completed her core and specialty urological training. She has finished her reconstructive sub-specialty training in genitourinary reconstructive surgery at the Institute of Urology, University College Hospital in London. Her research interests are primarily focused on urethral/bladder reconstruction, incontinence, and artificial urinary sphincter surgery. Dr. Ivaz has a special interest in medical education, quality and safety, and research and development. While her focus is on urologic reconstruction, she has published on a variety of other areas of interest, including general urology and medical education.

Giulia Lane

Giulia Lane

MD - United States

Giulia Lane is a current fellow in Female Pelvic Medicine and Reconstructive Surgery at the University of Michigan. As part of this fellowship she will complete Master’s degree in Health and Healthcare Research. Giulia completed her undergraduate and medical school degrees in Texas prior to moving to the University of Minnesota for Urology residency. She is a member of the American Urological Society (AUA), Society of Women in Urology (SWIU) and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU).  She has published research on the management of neurogenic bladder, patient report outcomes in nephrolithiasis, and bladder cancer. She is currently interested in characterizing underactive bladder and in the development and use of shared decision making tools in female pelvic medicine and neurourology. She also has interest in social media in medicine and has written Op-(m)ed articles for Doximity and participates in podcasts with BJUI.  In her free time, she enjoys spending time with her family, traveling, reading and music.

Dmitriy Nikolavsky

Dmitriy Nikolavsky

MD - United States

Dr. Dmitriy Nikolavsky earned his medical degree from Wayne State University School of Medicine in 2005 after completing his Bachelor’s degree in Biochemistry at University of Detroit Mercy in 2000.  He completed his internship in General Surgery in 2007 and subsequently his residency in Urology in 2011, both at William Beaumont Hospital in Royal Oak, Michigan.  He went on to train at the University of Colorado as a fellow in genitourinary reconstruction in 2011. He then joined the faculty at SUNY Upstate Medical University in Syracuse, NY with an appointment as Assistant Professor in Urology and Director of Reconstructive Urology in 2012. 

Dr. Nikolavsky runs a busy practice that focuses on reconstructive urology. His clinical interests include urethral reconstruction, fistula, male incontinence and correction of complications of transgender surgery. He holds a wide array of research interests, encompassing both clinical and patient-reported outcomes of urologic reconstruction, and development of novel techniques for urethral and ureteral reconstruction. He is working in collaboration with several centers in the US and worldwide on projects ranging from bench research to clinical outcomes studies.

Dr. Nikolavsky is a member of the Société Internationale d’Urologie (SIU), American Urological Association (AUA), Society of Genitourinary Reconstructive Surgeons (GURS) and International Russian-speaking Urological Society (iRUS). Since 2012, he has served as the Program Director/AUA Liaison for the Russian Language Session at the AUA annual meeting.

Arabind Panda

Arabind Panda

MS, MCh - India

Dr. Panda is Associate Professor of Urology at the Christian Medical College hospital, Vellore, India. He completed his Urological training in 2009 and has been focusing mainly on reconstructive urology and genitourinary trauma.

He has been an associate editor of the Indian Journal of Urology  for the past 5 years. He is particularly interested in reconstructive surgery of the urethra, both male and female; particularly in difficult posterior urethroplasty apart from vesicovaginal and rectourethral fistulas. He was awarded the 2014 AUA/IAUA Chakrobortty fellowship  by the American Urological Association and the 2013 the Klinikum Luneburg German Fellowship 2013.

He is closely involved in mentorship and training of urological residents and has more than 13 publications.

Jack Zuckerman

Jack Zuckerman

MD - United States

Dr. Zuckerman attended medical school at Wake Forest University School of Medicine.  He completed an internship in General Surgery at the Naval Medical Center in San Diego and then went on to complete Urology residency at Eastern Virginia Medical School in Norfolk, Virginia.  He finished his training at EVMS with a fellowship in genitourinary reconstructive surgery.  He recently returned to California and is faculty at the Naval Medical Center in San Diego.

 Dr. Zuckerman’’s research interests are primarily focused on male reconstruction, including ongoing prospective randomized controlled trials, basic science animal models and large clinical databases.  While his focus is on urologic reconstruction he has published on a variety of other urologic topics, including oncology and general urology.

 

Uro-oncology - Kidney

Joseph Ischia

Joseph Ischia

MD - Australia

Jose Karam

Jose Karam

MD, FACS - United States

Tobias Klatte

Tobias Klatte

MD - Austria

 

Uro-oncology - Prostate

Brian Chapin

Brian Chapin

MD - United States

Dr. Brian Chapin is an Assistant Professor in the Department of Urology at The University of Texas MD Anderson Cancer Center.  He provides complete surgical care for men and women diagnosed with urologic malignancies. He performs open surgery and minimally invasive/robotic surgery, for patients with prostate, kidney, bladder and testis cancers.  His major clinical focus is on the treatment of high risk- localized, locally advanced and metastatic prostate cancers. He has active clinical research protocols developing the integration of surgical, radiation and medical therapies in the treatment of advanced prostate cancer.  Dr. Chapin is involved with the basic science/translational research program at M.D Anderson, which is attempting to identify the immunologic changes that occur with surgical and systemic therapy treatments in advanced prostate cancer and how these changes may be exploited with use of newer immune modulating therapies.  Using a comprehensive multimodality approach to this disease, Dr. Chapin’s goal is to ease suffering and prolong survival in men with advanced prostate cancer.      

Lukman Hakim

Lukman Hakim

MD, Sp.U, MARS.,PhD - Indonesia

Dr. Lukam Hakim is currently a urologist at the Department of Urology, Airlangga University in Surabaya, Indonesia. In addition to his primary responsibility as a clinician focusing on uro-oncology and functional urology, he is head of the urology clinical training programme. He is currently the Vice-chair of the Advisory Board for the Faculty of Medicine.

Dr. Hakim received his clinical training in urology and earned a master’s degree in Hospital Administration from Airlangga University. He was granted a doctoral degree from KU Leuven in Belgium in 2015 under the supervision of Dirk De Ridder. Having a strong interest in the field of urology, Dr. Hakim continued with several clinical fellowships in Uro-oncology and Functional Urology between 2010 and 2015.

In the preclinical setting, Dr. Hakim is strongly focused on the application of stem cells in the treatment of urological disorders. He is currently a member of Airlangga University Stem Cell Research and Development and leads several projects on this research.

Dr. Hakim is a member of several associations including the European Association of Urology (EAU), the Societé Internationale d’Urologie (SIU), the American Urological Association (AUA), Indonesian Urological Association (IAUI), Indonesian Society of Uro-oncology (ISUO) and International Society of Stem Cell Research (ISSCR). Within the Indonesian urological community,
Dr. Hakim was the immediate Past-secretary general, and within the Asia-Pacific community, he is currently an executive board member of Asia Pacific Society of Uro-oncology (APSU) and Asia Pacific Prostate Society (APPS) as of 2017.

Dr. Hakim has published several articles related to clinical urology and stem cell application. He is also active in peer-reviewed journals including  BJUI, the Journal of Urology, Urologia Internationalis, Indonesian Journal of Urology, Journal of Medical Case Reports, BMC Urology, Journal of Men’s Health and Urological Science.

Markus Hohenfellner

Markus Hohenfellner

MD, PhD - Germany

Dr. Marcus Hohenfellner is Professor and Medical Director at the Department of Urology, University of Heidelberg, Germany. He is a board-certified Urologist.

Dr. Hohenfellner has a strong interest in cancer surgery of the kidney, retroperitoneum and small pelvis; minimally invasive urology, Da Vinci robotic surgery, reconstructive bladder replacement and ultra-radical cancer surgery.

He received training in general surgery at the Department of Surgery, and nephrology and basic research at the Department of Physiology, University of Munich. He completed his residency within the Department of Urology and Pediatric Urology, and the Department of Urology, at the University of Witten/Herdecke, Klinikum Barmen, Wuppertal. He completed a fellowship in Urology at University of California, San Franscico.

Dr. Hohenfellner is a member of several national and international urological societies including the German Urological Association (DGU), the European Association of Urology (EAU), the American Urological Association (AUA), the Austrian Urological Association (ÖGU), the Urologic Research Society and the German Transplantation Society.

He has authored more than 100 scientific papers and over 25 book chapters. He has more than 100 published contributions to scientific meetings in addition to two urological science textbooks.

Dr. Hohenfellner is the recipient of numerous awards including the Miley B. Wesson Resident Essay Contest, Western Section, American Urological Association; Forum Urodynamicum Prize, Forum Urodynamicum;  Jack Lapides Essay Contest (Grand Prize Award); Maximilian-Nitze Prize, German Association of Urology; EAU Thesis Award, European Association of Urology; and the C.E. Alken Prize.

Mohamed Jalloh

Mohamed Jalloh

MD - Senegal

Dr. Mohamed Jalloh is a urologist trained in Senegal (West Africa) and working as a consultant urologist at the Hôpital General de Grand Yoff, Dakar and coordinating the department of Medical Information.

He has expertise in the treatment of urological cancers and research on prostate cancer in men of African descent. He contributed to running an NIH funded research project on prostate cancer under Dr. Serigne Gueye co-PI in collaboration with Dr. Timothy Rebbeck co-PI from University of Harvard. This research focused on a better understanding of clinical and molecular epidemiology of prostate cancer in Senegalese men with an emphasis on developing research infrastructure. The research was further enlarged in a consortium – the Men of African Descent Carcinoma of the Prostate (MADCaP).

In 2013, he completed a UCSF/SIU post-doctoral scholarship training in Urologic Oncology at the University of California San Francisco under Dr. Peter R. Carroll, MD and published peer reviewed papers on prostate cancer.

Dr. Jalloh is the chair of the Developing World Sub-committee of the SIU Multimedia Learning Committee (MLC) since 2015.

In 2015, he completed a Master of Public Health: Management and Control of health programme at the University Alioune Diop of Bambey, Senegal. He is a part time lecturer in urology at the University Saint Christopher of Dakar and in public health at the University Alioune Diop of Bambey. Dr. Mohamed Jalloh is currently an investigator in a NIH/NCI U01 grant funded to this consortium to study the genetics of prostate cancer in Sub Saharan Africa.

Shancheng Ren

Shancheng Ren

MD - China

Dr. Shancheng Ren is a Chinese army doctor who completed his medical training and got a phD degree at the Second Military Medical University in 2009. He was sponsored by China Scholarship Council to University of California, San Francisco and trained as joint PhD student from 2008 to 2010. He is now associate professor in Urology at Shanghai Changhai Hospital. His clinical interest is robotic-assisted radical prostatectomy and research interest is the early diagnosis biomarkers for prostate cancer. He enjoys traveling during his free time.

Tilman Todenhöfer

Tilman Todenhöfer

MD - Germany

Tilman Todenhöfer is a urologist at the department of Urology of the Eberhard-Karls-University Tuebingen, Germany (Chairman: A. Stenzl). He has completed a postdoctoral research fellowship at the Vancouver Prostate Centre, Canada. His main fields of interest are circulating biomarkers in advanced prostate and bladder cancer, urine markers for detection of bladder cancer and the inhibition of metabolic pathways for treatment of advanced urothelial carcinoma. He has published more than 80 articles and has received various awards including the Alken Prize, the John-Blandy Prize, the CUA/CUOG research award and the German prostate cancer research award

 

Uro-oncology - Testis and Penile

Steve Riggs

Steve Riggs

MD - United States

Dr. Steve Riggs is currently an Associate Professor within the Division of Urology, Surgical Care Division and Levine Cancer Institute in Charlotte, NC. He completed his Oncology fellowship in 2008 at the University of California Los Angles Medical Center. Following this, he accepted an appointment to the Department of Urology, Eastern Virginia Medical Center before relocating to Charlotte. He has an active clinical practice in Urologic Oncology that includes a strong interest in writing and conducting clinical trials. He also has an avid interest in clinical and collaborative translational research. He is director of the institutes’ Cancer conferences, Urologic Oncology fellowship and site director for the Urology resident training that occurs in Charlotte. He has authored or co-authored multiple peer-reviewed manuscripts, editorials and invited articles in addition to serving in local and national leadership roles within the field of Urologic Oncology.

Fernando Secin

Fernando Secin

MD, PhD - Argentina

Fernando P. Secin, MD, PhD, is a Urologist Oncologist trained at Memorial Sloan Kettering Cancer Center, NY, USA. He currently works at CEMIC University Hospital and San Lazaro Foundation in Buenos Aires, Argentina. Dr. Secin is an Assistant Professor of Urology at the University of Buenos Aires School of Medicine and at CEMIC University Hospital.